ELN | Jotup

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Retrieved on:

Tuesday, March 26, 2024

The study is currently enrolling a 12-patient expansion cohort evaluating voruciclib administered at 300 mg daily for two weeks in a four-week cycle in combination with venetoclax.

Key Points:

The study is currently enrolling a 12-patient expansion cohort evaluating voruciclib administered at 300 mg daily for two weeks in a four-week cycle in combination with venetoclax.
A total of 29 patients with R/R AML, median age 67 years (range 34-89), enrolled in the dose escalation stage of the study evaluating voruciclib in combination with venetoclax.
The primary objectives of the study are to determine the safety and biologic effective dose of voruciclib monotherapy or voruciclib in combination with venetoclax.
Secondary objectives of the study include assessing the preliminary efficacy, pharmacokinetics, pharmacodynamics, and biomarkers of voruciclib monotherapy or voruciclib in combination with venetoclax.

Genseq Selects Sapio LIMS to Power Best-in-Class Next-Generation Sequencing Services

Retrieved on:

Monday, March 18, 2024

Founded in 2023, Genseq uses state-of-the-art sequencing platforms, including Novaseq, Nextseq, and Nextseq Dx, to ensure excellent quality and accuracy in sequencing data generation.

Key Points:

Founded in 2023, Genseq uses state-of-the-art sequencing platforms, including Novaseq, Nextseq, and Nextseq Dx, to ensure excellent quality and accuracy in sequencing data generation.
In addition to providing a full range of genomics, transcriptomics, and single-cell sequencing services, Genseq’s biobanking facility can accommodate more than 500,000 samples.
Genseq will use the advanced LIMS functionality from Sapio to track all aspects of sample management , including sample accessioning, storage, quality control, and aliquoting.
“Sapio is supporting Genseq in meeting its promise to clients, and we’re excited to partner with them as they grow their capabilities to meet demand.”

Dotmatics' LabArchives ELN Solution Achieves "In Process" Designation from FedRAMP, Sponsored by National Institutes of Health

Retrieved on:

Thursday, April 4, 2024

BOSTON, April 4, 2024 /PRNewswire/ -- Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced that its LabArchives for Government solution has achieved the "In-Process" designation granted by the Federal Risk and Authorization Management Program (FedRAMP®). LabArchives' FedRAMP application is sponsored by the National Cancer Institute of the National Institutes of Health (NIH). LabArchives lets organizations securely organize, search, and share data in a powerful electronic lab notebook (ELN) that supports scientific research and breakthroughs. The news is a critical milestone on the path to attaining FedRAMP authorization. LabArchives for Government is now listed on the FedRAMP Marketplace and will operate as a trusted partner to federal agencies upon authorization.

Key Points:

LabArchives' FedRAMP application is sponsored by the National Cancer Institute of the National Institutes of Health (NIH).
LabArchives lets organizations securely organize, search, and share data in a powerful electronic lab notebook (ELN) that supports scientific research and breakthroughs.
LabArchives for Government is now listed on the FedRAMP Marketplace and will operate as a trusted partner to federal agencies upon authorization.
FedRAMP is the U.S. government program that provides a safe, standardized approach to security and risk assessment for cloud technologies.

Introducing Assay Performance Monitoring for the Automated Assessment of Assay Data Quality in Real Time

Retrieved on:

Monday, March 4, 2024

Bias, Artificial intelligence, Information management, Drug discovery, Assay, Quality control, ELN, Surface plasmon resonance, Classification, Organization, Automation, BLI, SPR, Fine chemical

BASEL, Switzerland, March 4, 2024 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Screener®, its enterprise platform for automated assay data analytics and consolidated assay information management across an enterprise. The new version features as a new module, Assay Performance Monitoring, the first commercially available solution for monitoring assay data quality in the context of historical data. Included in the most comprehensive assay analytics platform on the market, Genedata Screener 21 sets new standards for data quality assessment and automated data processing that produce higher result quality, accelerated workflows coupled with increased consistency, improved scientific efficiency, and shortened timelines for molecule discovery and development.

Key Points:

The new version features as a new module, Assay Performance Monitoring, the first commercially available solution for monitoring assay data quality in the context of historical data.
Developed in close collaboration with leading biopharma companies, Genedata Screener 21 offers a new integrated solution for continuous assessment of assay quality, enabling the automated identification of experimental issues without delay.
Without a suitable enterprise solution, assay scientists spend hours manually compiling assay performance data, often bouncing between software tools.
Routine assay performance assessment in Screener using the new Assay Performance Monitoring module follows industry best-practices and ensures that assay quality standards are met without the need for manual data compilation.

Science Exchange Unveils Supplier Orchestration Platform for Life Sciences Organizations

Retrieved on:

Tuesday, January 30, 2024

Science Exchange, a leader in life sciences purchasing and supplier management, announces the release of its first-ever supplier orchestration platform.

Key Points:

Science Exchange, a leader in life sciences purchasing and supplier management, announces the release of its first-ever supplier orchestration platform.
Designed specifically for life sciences companies, this innovative solution aims to harmonize the complex procurement and supplier management process, enabling faster supplier collaboration and lower R&D costs.
The new Science Exchange Platform addresses these pain points head-on, offering a comprehensive technology solution to streamline intake, purchasing, supplier management, data transfer, and payment processing across a company’s supply base.
To discover how supplier orchestration can transform your organization's procurement operations and advance scientific research, visit scienceexchange.com .

IDBS announces data management partnership with PharmaEssentia Innovation Research Center

Retrieved on:

Tuesday, January 23, 2024

PIRC, Health, Data management, Paper, Multimedia, ELN, Partnership, Biopharmaceutical, Polar, Drug development, Therapy, BPLM, Electronic lab notebook, IDBS, Creative industries

WOKING, England, Jan. 23, 2024 /PRNewswire/ -- IDBS announced today that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on its Polar platform to help digitize data management and facilitate collaboration between the company's global research and development (R&D) teams.

Key Points:

WOKING, England, Jan. 23, 2024 /PRNewswire/ -- IDBS announced today that it has entered into a partnership with Massachusetts-based PharmaEssentia Innovation Research Center (PIRC) on its Polar platform to help digitize data management and facilitate collaboration between the company's global research and development (R&D) teams.
IDBS helps BioPharmaceutical organizations accelerate the discovery, development and manufacturing of the next generation of life-changing therapies that advance human health worldwide.
Known for its signature IDBS E-WorkBook product, IDBS has extended solutions across the entire value chain for BioPharma Lifecycle Management (BPLM) .
Built on analytics-centric and cloud-native technology, IDBS Polar and IDBS PIMS platforms are powered by a digital data backbone to drive faster and smarter decisions in drug development and across the supply chain.

Scispot Introduces Lab Operating System and GLUE on AWS Marketplace

Retrieved on:

Thursday, January 18, 2024

HIPAA, OS, GDPR, Data management, Amazon, ELN, API, Amazon Web Services, GLUE, Data science, AI, Centralisation, Gen, Laboratory information management system, AWS, CFR, LIMS

KITCHENER, ON, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Scispot, a leading provider of biotech tech stack, today announced the availability of its products, Lab Operating System (OS) and GLUE, on AWS Marketplace.

Key Points:

KITCHENER, ON, Jan. 18, 2024 /PRNewswire-PRWeb/ -- Scispot, a leading provider of biotech tech stack, today announced the availability of its products, Lab Operating System (OS) and GLUE, on AWS Marketplace.
Biotech companies will now have the option to purchase a Scispot license leveraging their Amazon Web Services (AWS) credits and pre-negotiated contracts with AWS.
Scispot GLUE provides a scientific data and instrument connectivity toolkit to streamline lab instrument integration and render R&D data AI-ready.
Scispot listing on AWS Marketplace provide AWS biotech customers with:
A quicker approach to harmonize their R&D data utilizing their existing AWS budget.

Global Electronic Laboratory Notebooks (ELNs) Strategic Research Report 2024

Retrieved on:

Wednesday, January 17, 2024

Stroke, Central Statistics Office (India), Growth, Data management, Others, ELN, Specific, Fatality, Cardiovascular disease, Organization, Electronic lab notebook, Informatics, Chronic condition, Incidence, Pet industry

DUBLIN, Jan. 17, 2024 /PRNewswire/ -- The "Electronic Laboratory Notebooks (ELNs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points:

DUBLIN, Jan. 17, 2024 /PRNewswire/ -- The "Electronic Laboratory Notebooks (ELNs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The pandemic has had a notable impact on the Laboratory Informatics Market, with increased demand for Electronic Laboratory Notebooks (ELNs) as their benefits became more apparent during these challenging times.
Electronic Laboratory Notebooks (ELNs) have gained prominence as they offer a digital solution to replace traditional paper-based laboratory notebooks.
Electronic Laboratory Notebooks (ELNs) is a significant segment within the laboratory informatics market, with various players competing actively.

Sapio Sciences Announces Full GxP Validation of its Unified Lab Informatics Platform and Suite of Solutions

Retrieved on:

Thursday, January 11, 2024

Sapio Sciences , the science-aware™ lab informatics platform , today announced that its unified platform for research and clinical informatics has been validated to comply with “good practice” quality guidelines and regulations.

Key Points:

Sapio Sciences , the science-aware™ lab informatics platform , today announced that its unified platform for research and clinical informatics has been validated to comply with “good practice” quality guidelines and regulations.
GxP refers to good practice quality guidelines and regulations that span various industries, including pharmaceutical and biotech companies and contract development and manufacturing organizations (CDMOs), which Sapio’s platform serves.
In addition to validating its software, Sapio has also developed a premium validation package for its customers.
Visit the Sapio website for a guide reviewing the impact of GxP on life science organizations.

Scitara Joins Snowflake Partner Network

Retrieved on:

Thursday, December 14, 2023

As part of the Snowflake Partner Network, Scitara can help joint customers get the most out of the Snowflake Data Cloud.

Key Points:

As part of the Snowflake Partner Network, Scitara can help joint customers get the most out of the Snowflake Data Cloud.
“Scitara is proud to partner with Snowflake and bring our collective capabilities and expertise to our joint customers and offer a truly next generation data cloud solution for lab data,” Ajit Nagral, CEO of Scitara.
Scitara and Snowflake , the Data Cloud Company, are working together to mobilize the world’s laboratory data with Snowflake’s Data Cloud.
The Snowflake Partner Network unlocks the potential of the Data Cloud with a broad array of tools and partners.